The Mitochondrial Research Archive

A curated library of peer-reviewed literature exploring the frontiers of cellular energy,
metabolic resilience, and the science of human vitality.

Epicatechin, Obesity, and Cardiometabolic Risk

Study Title: Effects of (−)-epicatechin on a diet-induced rat model of cardiometabolic risk factors

Citation: Gutiérrez-Salmeán et al., 2014. European Journal of Pharmacology

What the Study Found: This study used a high-fat diet rat model and found that (−)-epicatechin reduced weight gain, blood glucose, triglycerides, and blood pressure. It also restored key mitochondrial-related proteins such as PGC-1α, TFAM, and UCP1, which are involved in energy production and metabolic regulation.

What this means in real life: This study shows that cardiometabolic risk is closely tied to how well mitochondria regulate energy and metabolism. It suggests that improving cellular energy systems may influence weight, blood sugar, and lipid balance at the same time.

Contenido relacionado: